- Home
- DCTH vs ARQQ Comparison
DCTH vs ARQQ Comparison
Compare DCTH & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DCTH | ARQQ |
|---|---|---|
| Founded | 1988 | 2017 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 350.7M | 351.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DCTH | ARQQ |
|---|---|---|
| Price | $10.06 | $25.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $22.60 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 716.2K | 358.7K |
| Earning Date | 11-04-2025 | 12-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $79,603,000.00 | $530,000.00 |
| Revenue This Year | $131.97 | $1,054.72 |
| Revenue Next Year | $38.84 | N/A |
| P/E Ratio | $287.78 | ★ N/A |
| Revenue Growth | ★ 251.54 | N/A |
| 52 Week Low | $8.12 | $11.00 |
| 52 Week High | $18.23 | $62.00 |
Technical Indicators
Market Signals| Indicator | DCTH | ARQQ |
|---|---|---|
| Relative Strength Index (RSI) | 55.89 | 43.12 |
| Support Level | $9.84 | $22.38 |
| Resistance Level | $10.28 | $25.73 |
| Average True Range (ATR) | 0.45 | 2.54 |
| MACD | 0.04 | -0.06 |
| Stochastic Oscillator | 57.50 | 35.97 |
Price Performance
Historical ComparisonAbout DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.